Vaxcyte, Inc. (PCVX)
NASDAQ
Real-time Data
01:30 PM
Day's Range
61.6052 wk Range
29.87Overview - PCVX - Vaxcyte, Inc.
Key Statistics
Valuation
Enterprise Value
7.83B
P/E (Trailing)
‪-10.85‬
P/E (Forward)
‪-8.60‬
PEG Ratio
‪-0.17‬
Price / Book
‪3.26‬
EV / EBITDA
‪-6.82‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-22.60%‬
Return on Equity
‪-36.51%‬
Ownership
Shares Outstanding
144.78M
Float
136.17M
Short % of Shares Outstanding
‪10.04%‬
Held by Insiders
‪0.48%‬
Held by Institutions
‪113.44%‬
Price stats
Beta
‪1.21‬
50-Day Avg
‪56.42‬
200-Day Avg
‪53.32‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
11 analysts
Average price target
‪$ 109.00‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - PCVX - Vaxcyte, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PCVXNASDAQVaxcyte, Inc.9.31BMarket Cap+51.37%52-week change-11.11P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt63.39BMarket Cap+30.55%52-week change39.65P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc32.12BMarket Cap-87.94%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE28.64BMarket Cap+7.89%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.52BMarket Cap+21.81%52-week change19.30P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.71BMarket Cap+38.32%52-week change-21.28P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.79BMarket Cap+11.28%52-week change174.00P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - PCVX - Vaxcyte, Inc.
About
Vaxcyte Inc. is a biotechnology company focused on developing innovative vaccines for preventing infectious diseases. The primary objective of the company is to create safer and more effective vaccines using its proprietary cell-free protein synthesis platform, a groundbreaking technology that aims to enhance vaccine…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
